Client 1 St Advisory Group, LLC Astrazeneca PLC Transaction History

Client 1 St Advisory Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $270,576 - $325,934	-4,856 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$48.42 - $60.18 $40,818 - $50,731	-843 Reduced 14.79%	4,856 $291,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $71,801 - $97,527	-1,900 Reduced 25.0%	5,699 $255,000
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $322,653 - $383,445	7,599 New	7,599 $379,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Client 1 St Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Client 1 St Advisory Group, LLC with notifications on news.